Breaking News, Promotions & Moves

Neurvati Neurosciences Appoints New Chief Commercial Officer

Carlos Martin joins the company with over 20 years of leadership experience.

By: Rachel Klemovitch

Assistant Editor

Neurvati Neurosciences, the neuroscience development platform of Blackstone Life Sciences, appointed Carlos Martin as Chief Commercial Officer (CCO).  With Martin’s appointment, Neurvati reinforces its model as a neuroscience company built for impact: bridging rigorous science with the scientific, operational, and commercial expertise required to deliver breakthroughs to patients globally. Martin brings over 20 years of leadership experience across global biopharmaceutical markets, w...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters